Page last updated: 2024-08-18

cyclohexanol and Cardiac Failure

cyclohexanol has been researched along with Cardiac Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, PC; Gomes, T; Ho, JM; Juurlink, DN; Mamdani, M; Straus, SE1
Capron, A; Classen, JF; Hantson, P; Haufroid, V; Marchandise, S; Vinetti, M1
Batista, M; Bonbled, F; Capron, A; Dugernier, T; Fonseca, S; Hantson, P; Haufroid, V; Simon, M1
Bekers, O; Drent, M; du Bois, RM; Gorgels, AP; Hansell, DM; Nicholson, AG; Singh, S; van Suylen, RJ1
Chatani, F; Kitayoshi, T; Nishimura, S; Watanabe, T; Yamamoto, K1
Berry, BD; Colucci, VJ1

Other Studies

6 other study(ies) available for cyclohexanol and Cardiac Failure

ArticleYear
Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
    The Journal of clinical psychiatry, 2014, Volume: 75, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride

2014
Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.
    Clinical toxicology (Philadelphia, Pa.), 2011, Volume: 49, Issue:9

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cardiomyopathies; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Drug Overdose; Female; Gene Deletion; Half-Life; Heart Failure; Humans; Milrinone; Norepinephrine; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2011
The spectrum of acute heart failure after venlafaxine overdose.
    Clinical toxicology (Philadelphia, Pa.), 2013, Volume: 51, Issue:2

    Topics: Acute Disease; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Death, Sudden, Cardiac; Delayed-Action Preparations; Electrocardiography; Epilepsy, Tonic-Clonic; Fatal Outcome; Female; Heart Failure; Humans; Hypoxia; Long QT Syndrome; Middle Aged; Respiration, Artificial; Serotonin Syndrome; Shock, Cardiogenic; Stroke Volume; Suicide, Attempted; Venlafaxine Hydrochloride; Ventricular Function, Left

2013
Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine.
    American journal of respiratory and critical care medicine, 2003, Apr-01, Volume: 167, Issue:7

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Pneumonia; Venlafaxine Hydrochloride; Ventricular Dysfunction, Left

2003
Absence of interactive effects of trans-1,2-cyclohexanediol, a major metabolite of the side-chain of candesartan cilexetil, on digoxin-induced arrhythmias in dogs.
    Journal of pharmacological sciences, 2003, Volume: 92, Issue:4

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Cyclohexanols; Digoxin; Dogs; Drug Interactions; Guinea Pigs; Heart Failure; In Vitro Techniques; Male; Papillary Muscles; Tetrazoles

2003
Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:6

    Topics: Adult; Aged; Cyclohexanols; Duloxetine Hydrochloride; Female; Heart Failure; Humans; Male; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Tachycardia; Thiophenes; Venlafaxine Hydrochloride; Ventricular Dysfunction, Left

2008